单位(元)易方达医药生物股票A(010387)资产负债表 |
| 报告期 |
2024/12/31 |
2024/6/30 |
2023/12/31 |
2023/6/30 |
| 资产 |
| 银行存款 |
311,434,310 |
229,586,178 |
226,362,512 |
184,567,092 |
| 结算备付金 |
8,165,088 |
2,255,991 |
2,805,126 |
4,800,364 |
| 存出保证金 |
330,711 |
248,011 |
211,880 |
546,522 |
| 交易性金融资产 |
2,911,745,668 |
2,874,084,619 |
3,440,939,765 |
2,521,094,859 |
| 其中：股票投资 |
2,911,745,668 |
2,870,873,883 |
3,439,204,659 |
2,519,479,877 |
| 基金投资 |
- |
- |
- |
- |
| 债券投资 |
- |
3,210,735 |
1,735,106 |
1,614,982 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
70,136,248 |
9,213,684 |
7,134,670 |
3,024,892 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
1,792,376 |
- |
154,456 |
| 应收申购款 |
3,518,647 |
22,328,145 |
4,814,807 |
1,718,485 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
3,305,330,672 |
3,139,509,003 |
3,682,268,761 |
2,715,906,671 |
| 负债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
12,433,873 |
5,398,901 |
7,698 |
8,094,431 |
| 应付赎回款 |
160,772,902 |
6,318,103 |
26,143,485 |
3,255,021 |
| 应付管理人报酬 |
3,503,833 |
3,186,996 |
3,736,207 |
3,487,293 |
| 应付托管费 |
583,972 |
531,166 |
622,701 |
581,215 |
| 应付销售服务费 |
447,465 |
390,276 |
473,973 |
230,120 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
7 |
3 |
28 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
1,397,672 |
896,831 |
1,604,764 |
1,472,788 |
| 负债合计 |
179,139,717 |
16,722,281 |
32,588,832 |
17,120,896 |
| 所有者权益 |
| 实收基金 |
5,302,435,396 |
5,396,093,560 |
5,573,837,253 |
4,384,352,607 |
| 未分配利润 |
-2,176,244,441 |
-2,273,306,838 |
-1,924,157,324 |
-1,685,566,832 |
| 所有者权益合计 |
3,126,190,955 |
3,122,786,722 |
3,649,679,929 |
2,698,785,775 |
| 负债和所有者权益总计 |
3,305,330,672 |
3,139,509,003 |
3,682,268,761 |
2,715,906,671 |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
